Compare Docusign Inc (DOCU) vs Lam Research Corporation (LRCX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Docusign Inc vs Lam Research Corporation — how do they compare? Docusign Inc trades at $71.08 (market cap $13.35B), while Lam Research Corporation trades at $318.84 (market cap $401.19B). The key difference: Lam Research Corporation is far larger — about 30.1× Docusign Inc's market cap, and Lam Research Corporation pays a 0.41% dividend while Docusign Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Docusign Inc for 71 Days and Lam Research Corporation for 60 Days on average.
| DOCU | LRCX | |
|---|---|---|
Market Cap | $13.35B | $401.19B |
Volume | 3,158,858 | 8,960,892 |
Sector | Technology | Technology |
52-Week High | $73.14 | $433.33 |
52-Week Low | $41.75 | $131.37 |
Typical Hold Time | 71 Days | 60 Days |
Enterprise Value | $12.76B | $399.35B |
Dividend Yield | — | 0.41% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DOCU trades at $71.43, up 3.67% on the day, with a bullish technical signal and strong earnings beats in recent quarters. Revenue grew to $2.98B in 2025, with net income surging to $1.07B, though cash flow turned negative. The stock is supported by AI-driven IAM adoption and leadership in signing workflow software, as noted in recent news.
Outlook is mixed: growth from AI and market position offers upside, but high valuation (P/E 43.55), insider selling, and slowing revenue growth pose risks. Analyst consensus is cautious with a $68.75 target below current price, suggesting limited near-term gains amid competitive and execution challenges.
Lam Research (LRCX) trades at $320.59, down 2.71% on the day, amid a bearish technical signal despite strong fundamentals. The company reported robust earnings beats in recent quarters, with Q2 2026 EPS of $1.82 surpassing the $1.69 estimate, and maintains high profitability with a net income margin of 31.27%. Revenue growth is accelerating, reaching $18.44 billion in 2025, supported by AI-driven demand for semiconductor equipment. Analyst consensus remains strongly bullish with a $375.68 price target, though technical indicators show mixed signals with key support at $314.
LRCX presents a compelling long-term investment opportunity driven by AI infrastructure spending and operational efficiency, but faces near-term volatility from technical bearishness and macroeconomic headwinds. Risks include cyclical semiconductor demand and competitive pressures, yet strong institutional support and consistent earnings outperformance underpin upside potential toward analyst targets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Docusign Inc
DocuSign offers the Agreement Cloud, a broad cloud-based software suite that enables users to automate the agreement process and provide legally binding e-signatures from nearly any device. The company was founded in 2003 and completed its IPO in May 2018.
Read more on DOCU →About Lam Research Corporation
Lam Research manufactures equipment used to fabricate semiconductors. The firm is focused on the etching, deposition, and clean markets, which are key steps in the semiconductor manufacturing process, especially for 3D NAND flash storage, advanced DRAM, and leading-edge logic/foundry chipmakers. Lam's flagship Kiyo, Vector, and Sabre products are sold in all major geographies to key customers such as Samsung Electronics, Micron, Intel, and Taiwan Semiconductor Manufacturing.
Read more on LRCX →
